CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,683 | -37.0% | 4,210 | 0.0% | 0.00% | – |
Q2 2023 | $15,366 | +156.1% | 4,210 | +72.3% | 0.00% | – |
Q2 2022 | $6,000 | -94.8% | 2,443 | -89.8% | 0.00% | – |
Q1 2022 | $116,000 | -57.0% | 23,946 | 0.0% | 0.00% | – |
Q4 2021 | $270,000 | +28.0% | 23,946 | +65.1% | 0.00% | – |
Q3 2021 | $211,000 | +99.1% | 14,507 | +59.0% | 0.00% | – |
Q2 2021 | $106,000 | -7.8% | 9,126 | -3.8% | 0.00% | – |
Q1 2021 | $115,000 | -0.9% | 9,489 | +2.0% | 0.00% | – |
Q4 2020 | $116,000 | -17.1% | 9,299 | 0.0% | 0.00% | – |
Q3 2020 | $140,000 | -45.3% | 9,299 | -10.9% | 0.00% | – |
Q2 2020 | $256,000 | +481.8% | 10,442 | +235.0% | 0.00% | – |
Q1 2020 | $44,000 | -35.3% | 3,117 | -26.9% | 0.00% | – |
Q4 2019 | $68,000 | +126.7% | 4,265 | +20.9% | 0.00% | – |
Q3 2019 | $30,000 | +50.0% | 3,527 | +34.2% | 0.00% | – |
Q2 2019 | $20,000 | 0.0% | 2,628 | 0.0% | 0.00% | – |
Q1 2019 | $20,000 | +66.7% | 2,628 | 0.0% | 0.00% | – |
Q4 2018 | $12,000 | -50.0% | 2,628 | 0.0% | 0.00% | – |
Q3 2018 | $24,000 | -22.6% | 2,628 | 0.0% | 0.00% | – |
Q2 2018 | $31,000 | +40.9% | 2,628 | +68.6% | 0.00% | – |
Q1 2018 | $22,000 | – | 1,559 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |